Date
2020/12/1

2020/12/8

2020/12/15

2020/12/22
2021/1/5
2021/1/19
2021/1/26
2021/2/2

2021/2/9

2021/2/16
2021/3/9

2021/3/16

2021/3/23
2021/3/30

Presenter Title
A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL
坂本
undergoing allo-HCT: a prospective clinical cohort study
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
長井
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of桐野ANDROMEDAStandardization of 18 F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response
加藤Definition in Newly Diagnosed Multiple Myeloma
CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma:
渡辺
an intent-to-treat comparison
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
澤山
Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and山田
meta-analysis of 3377 patients
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
児嶋
FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells
安東Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and新山
Relapsed or Refractory Chronic Lymphocytic Leukemia
Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9
宮﨑
Short telomere length predicts nonrelapse mortality after stem cell transplantation for藤岡
myelodysplastic syndrome
Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease
佐藤Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an桐野international phase 3 study
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large
山田
B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
長井
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and渡辺matched unrelated donors
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features
波多in Myelodysplastic Syndromes
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse
児嶋large B-cell lymphoma
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical加藤
Hodgkin lymphoma
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs:
千綿First interim analysis of OPTkIMA study
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism
坂本Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias
安東Journal

Year

Vol

Page

Leukemia

2020

17-Nov

Online ahead of print.

Blood2020

136(20)2308-2318

Blood2020

136(1)

71-80

J Clin Oncol

2020

5-Nov

Online ahead of print.

Blood Adv

2020

4(24)

6157-6168

J Clin Oncol

2020

38(2)

155-165

Blood2020

136(25)2881-2892

N Eng J Med
Cell

2020
2020

383(26)18-Dec2526-2537
Online ahead of print.

J Clin Oncol

2020

38(1)

3626-3637

Blood2021

137(1)

75-88

Blood2020

136(26)3070-3081

N Eng J Med

2021

384(1）

11-19

Blood Adv

2021

5(3)

725-736

Lancet Haematol 2021

8(2)e110-e121

Blood

2021

137(5)

624-636

Blood Adv

2021

5(4)

975-983

J Clin Oncol

2021

39(11)

1223-1233

Blood

2021

137(5)

600-609

Blood2021

137(10)1318-1326

Cancer Med

2021

10(5)

1726-1737

Cancer CellNat Immunol

2021
2021

39(4)
22(4)

527-547
520-529